How to set up modern cold calling: step-by-step tutorial for healthcare and life sciences in emerging markets
A ten-step, do-it-in-a-week walkthrough for installing modern cold calling from scratch — including the exact tools, the sequence, and the checkpoints. Written for commercial leaders at healthtech, medtech, and life-sciences companies in emerging markets.
This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in emerging markets. In this market, emerging-market buyers reward patient capital, currency-aware pricing, and a real local operating footprint, so the way you install modern cold calling has to be shaped to that reality from day one.
This is the exact sequence we use to install modern cold calling when a client says "we want this live by Monday". Modern cold calling is using the phone as a precision tool, not a volume weapon, and everything below is designed so a single operator can run it end to end.
Step one: write down the account list. If you cannot name 200 companies, you do not yet have a target — you have a demographic. Refine until every account passes a "would we take their money?" gut check.
Step two: define the trigger. What has to be true in the world for you to touch this account this week? For modern cold calling, that trigger connects directly to connects per hour on ICP dials.
Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in emerging markets it is compounded by the fact that operating footprint and pricing fit, not brand awareness is what actually gates growth. Modern cold calling is only useful here when it is pointed at both constraints at once.
Steps three to five: pick the tools, wire the data, and dry-run against ten accounts. Do not scale until a human has read every artefact and would send it themselves.
Steps six and seven: go live at 20% of intended volume for one week. Track connects per hour on ICP dials daily, not weekly. Kill anything that misses the bar.
Steps eight to ten: ramp to full volume, publish a Friday review, and set the next 30-day target. Do not chase new tools until the current setup has run for a full month.
The most common tutorial failure is power dialers that torch the list in a week — usually in step six, when volume feels safe and copy quality slips. Guard step six with a checklist and a second pair of eyes.
Concretely for healthcare and life sciences in emerging markets: the healthcare teams that install this get past procurement instead of dying in it, and the teams that install this early own the category before Western vendors even show up. That is the reason it is worth installing modern cold calling deliberately for this market rather than importing a playbook designed for somewhere else.
Frequently asked questions
Sales · healthcare · emerging markets — answered
- Does modern cold calling work for healthcare and life sciences in emerging markets?
- Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in emerging markets, emerging-market buyers reward patient capital, currency-aware pricing, and a real local operating footprint. The healthcare teams that install this get past procurement instead of dying in it.
- How long does it take to set up modern cold calling?
- A single operator can be live inside a week; the model matures over 60 to 90 days.
- What is the first step for modern cold calling?
- Write the account list. Everything downstream is a function of who you are trying to reach.
- How do I know modern cold calling is working?
- Connects per hour on ICP dials moves in the right direction week over week, not month over month.
- What breaks first when scaling modern cold calling?
- Power dialers that torch the list in a week — usually the moment you ramp volume without a quality gate.
- What is the emerging markets-specific pitfall when running modern cold calling for healthcare?
- Importing a playbook that was built for another market. In emerging markets, emerging-market buyers reward patient capital, currency-aware pricing, and a real local operating footprint — the install has to reflect that.
Growth Broker editorial
Filed under sales · healthcare · emerging markets